245 related articles for article (PubMed ID: 12559801)
1. Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.
Iyer S; HogenEsch H; Hem SL
Vaccine; 2003 Mar; 21(11-12):1219-23. PubMed ID: 12559801
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants.
Romero Méndez IZ; Shi Y; HogenEsch H; Hem SL
Vaccine; 2007 Jan; 25(5):825-33. PubMed ID: 17014935
[TBL] [Abstract][Full Text] [Related]
3. Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield GL; Sokolovska A; Jiang D; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2005 Feb; 23(13):1588-95. PubMed ID: 15694511
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response.
Hansen B; Sokolovska A; HogenEsch H; Hem SL
Vaccine; 2007 Sep; 25(36):6618-24. PubMed ID: 17681647
[TBL] [Abstract][Full Text] [Related]
5. Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.
Shi Y; HogenEsch H; Hem SL
Vaccine; 2001 Oct; 20(1-2):80-5. PubMed ID: 11567749
[TBL] [Abstract][Full Text] [Related]
6. Effect of phosphorylation of ovalbumin on adsorption by aluminum-containing adjuvants and elution upon exposure to interstitial fluid.
Morefield GL; Jiang D; Romero-Mendez IZ; Geahlen RL; Hogenesch H; Hem SL
Vaccine; 2005 Feb; 23(12):1502-6. PubMed ID: 15670886
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of immunopotentiation by aluminum-containing adjuvants elucidated by the relationship between antigen retention at the inoculation site and the immune response.
Noe SM; Green MA; HogenEsch H; Hem SL
Vaccine; 2010 Apr; 28(20):3588-94. PubMed ID: 20211692
[TBL] [Abstract][Full Text] [Related]
8. Effect of the degree of phosphate substitution in aluminum hydroxide adjuvant on the adsorption of phosphorylated proteins.
Iyer S; HogenEsch H; Hem SL
Pharm Dev Technol; 2003; 8(1):81-6. PubMed ID: 12665200
[TBL] [Abstract][Full Text] [Related]
9. Degree of antigen adsorption in the vaccine or interstitial fluid and its effect on the antibody response in rabbits.
Chang M; Shi Y; Nail SL; HogenEsch H; Adams SB; White JL; Hem SL
Vaccine; 2001 Apr; 19(20-22):2884-9. PubMed ID: 11282199
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant.
Iyer S; Robinett RS; HogenEsch H; Hem SL
Vaccine; 2004 Mar; 22(11-12):1475-9. PubMed ID: 15063571
[TBL] [Abstract][Full Text] [Related]
11. Relationship of adsorption mechanism of antigens by aluminum-containing adjuvants to in vitro elution in interstitial fluid.
Jiang D; Morefield GL; HogenEsch H; Hem SL
Vaccine; 2006 Mar; 24(10):1665-9. PubMed ID: 16246468
[TBL] [Abstract][Full Text] [Related]
12. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
[TBL] [Abstract][Full Text] [Related]
13. The in vitro displacement of adsorbed model antigens from aluminium-containing adjuvants by interstitial proteins.
Heimlich JM; Regnier FE; White JL; Hem SL
Vaccine; 1999 Jul; 17(22):2873-81. PubMed ID: 10438058
[TBL] [Abstract][Full Text] [Related]
14. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles.
Li X; Aldayel AM; Cui Z
J Control Release; 2014 Jan; 173():148-57. PubMed ID: 24188959
[TBL] [Abstract][Full Text] [Related]
15. Formulation of botulinum neurotoxin heavy chain fragments for vaccine development: mechanisms of adsorption to an aluminum-containing adjuvant.
DePaz RA; Henderson I; Advant SJ
Vaccine; 2005 Jul; 23(31):4029-35. PubMed ID: 15963360
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants.
Jendrek S; Little SF; Hem S; Mitra G; Giardina S
Vaccine; 2003 Jun; 21(21-22):3011-8. PubMed ID: 12798645
[TBL] [Abstract][Full Text] [Related]
17. Use of a quartz crystal microbalance platform to study protein adsorption on aluminum hydroxide vaccine adjuvants: Focus on phosphate-hydroxide ligand exchanges.
Art JF; Soumillion P; Dupont-Gillain CC
Int J Pharm; 2020 Jan; 573():118834. PubMed ID: 31715342
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Antigen Adsorption Onto an Aluminum-Hydroxide Adjuvant Evaluated by High-Throughput Screening.
Jully V; Mathot F; Moniotte N; Préat V; Lemoine D
J Pharm Sci; 2016 Jun; 105(6):1829-1836. PubMed ID: 27238481
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Analysis of Vaccine Antigen Adsorption to Aluminum Adjuvant Using an Automated High-Throughput Method.
Ahl PL; Wang SC; Chintala R; Mensch C; Smith WJ; Wenger M; Blue J
PDA J Pharm Sci Technol; 2018; 72(2):149-162. PubMed ID: 29343619
[TBL] [Abstract][Full Text] [Related]
20. Distribution of adsorbed antigen in mono-valent and combination vaccines.
Morefield GL; HogenEsch H; Robinson JP; Hem SL
Vaccine; 2004 May; 22(15-16):1973-84. PubMed ID: 15121310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
